Filing Details
- Accession Number:
- 0001209191-23-059502
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-21 20:14:54
- Reporting Period:
- 2023-12-20
- Accepted Time:
- 2023-12-21 20:14:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1851194 | Ventyx Biosciences Inc. | VTYX | Pharmaceutical Preparations (2834) | 832996852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1874108 | John Nuss | C/O Ventyx Biosciences, Inc. 12790 El Camino Real, Suite 200 San Diego CA 92130 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-12-20 | 17,628 | $2.12 | 262,118 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stockunits.
- Represents the weighted average share price of an aggregate total of 17,628 shares sold in the price range of $2.07 to $2.155. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
